Milano_2022_Cancer.Sci__

Reference

Title : Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs - Milano_2022_Cancer.Sci__
Author(s) : Milano G , Innocenti F , Minami H
Ref : Cancer Sci , : , 2022
Abstract : Milano_2022_Cancer.Sci__
ESTHER : Milano_2022_Cancer.Sci__
PubMedSearch : Milano_2022_Cancer.Sci__
PubMedID: 35445479

Related information

Citations formats

Milano G, Innocenti F, Minami H (2022)
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs
Cancer Sci :

Milano G, Innocenti F, Minami H (2022)
Cancer Sci :